Folate may reduce binding of pafolacianine to folate receptors and could reduce detection of lesions. Avoid administration within 48 hours before CYTALUX.
Source: NLP:pafolacianine injection
Brand names: Cytalux
Route: Intravenous
Contraindications
4 CONTRAINDICATIONS None. None. (4)
2 interactions on record
Folate may reduce binding of pafolacianine to folate receptors and could reduce detection of lesions. Avoid administration within 48 hours before CYTALUX.
Source: NLP:pafolacianine injection
Folic acid may reduce binding of pafolacianine to folate receptors and could reduce detection of lesions. Avoid administration within 48 hours before CYTALUX.
Source: NLP:pafolacianine injection